AU2001260406A1 - Antidiarrheal cannabinoid cb-1 receptor antagonist - Google Patents
Antidiarrheal cannabinoid cb-1 receptor antagonistInfo
- Publication number
- AU2001260406A1 AU2001260406A1 AU2001260406A AU6040601A AU2001260406A1 AU 2001260406 A1 AU2001260406 A1 AU 2001260406A1 AU 2001260406 A AU2001260406 A AU 2001260406A AU 6040601 A AU6040601 A AU 6040601A AU 2001260406 A1 AU2001260406 A1 AU 2001260406A1
- Authority
- AU
- Australia
- Prior art keywords
- antidiarrheal
- cannabinoid
- receptor antagonist
- antagonist
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940123158 Cannabinoid CB1 receptor antagonist Drugs 0.000 title 1
- 230000001142 anti-diarrhea Effects 0.000 title 1
- 239000003555 cannabinoid 1 receptor antagonist Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR00/06178 | 2000-05-12 | ||
| FR0006178A FR2809621B1 (fr) | 2000-05-12 | 2000-05-12 | Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles comme antidiarrheiques |
| PCT/FR2001/001432 WO2001085092A2 (fr) | 2000-05-12 | 2001-05-11 | Antagoniste des recepteurs aux cannabinoides cb-1 antidiarrheique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001260406A1 true AU2001260406A1 (en) | 2001-11-20 |
Family
ID=8850242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001260406A Abandoned AU2001260406A1 (en) | 2000-05-12 | 2001-05-11 | Antidiarrheal cannabinoid cb-1 receptor antagonist |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2001260406A1 (fr) |
| FR (1) | FR2809621B1 (fr) |
| WO (1) | WO2001085092A2 (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ534757A (en) | 2002-03-12 | 2006-07-28 | Merck & Co Inc | Substituted amides |
| CA2479618A1 (fr) | 2002-03-26 | 2003-10-09 | William K. Hagmann | Amides spirocycliques en tant que modulateurs du recepteur cannabinoide |
| US7271266B2 (en) | 2002-03-28 | 2007-09-18 | Merck & Co., Inc. | Substituted 2,3-diphenyl pyridines |
| WO2003086288A2 (fr) | 2002-04-12 | 2003-10-23 | Merck & Co., Inc. | Amides bicycliques |
| US7129239B2 (en) | 2002-10-28 | 2006-10-31 | Pfizer Inc. | Purine compounds and uses thereof |
| US7247628B2 (en) | 2002-12-12 | 2007-07-24 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
| KR100704097B1 (ko) * | 2003-01-02 | 2007-04-06 | 에프. 호프만-라 로슈 아게 | 신규 cb 1 수용체 역작용제 |
| US7329658B2 (en) | 2003-02-06 | 2008-02-12 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
| US7176210B2 (en) | 2003-02-10 | 2007-02-13 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
| US7141669B2 (en) | 2003-04-23 | 2006-11-28 | Pfizer Inc. | Cannabiniod receptor ligands and uses thereof |
| US7268133B2 (en) | 2003-04-23 | 2007-09-11 | Pfizer, Inc. Patent Department | Cannabinoid receptor ligands and uses thereof |
| US7145012B2 (en) | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
| US7232823B2 (en) | 2003-06-09 | 2007-06-19 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
| EP1574211A1 (fr) | 2004-03-09 | 2005-09-14 | Inserm | Utilisation d'antagonistes des récepteurs CB1 pour la fabrication d'un médicament destiné au traitement des maladies hépatiques |
| CA2586011C (fr) | 2004-07-12 | 2011-07-19 | Cadila Healthcare Limited | Derives tricycliques de la pyrazole en tant que modulateurs de recepteurs cannabinoides |
| US20060025448A1 (en) | 2004-07-22 | 2006-02-02 | Cadila Healthcare Limited | Hair growth stimulators |
| WO2007039797A1 (fr) * | 2005-10-03 | 2007-04-12 | Pfizer Products Inc. | Utilisation d'antagonistes du recepteur cannabinoide de type 1 pour traiter les inflammations et l'arthrite |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2713225B1 (fr) * | 1993-12-02 | 1996-03-01 | Sanofi Sa | N-pipéridino-3-pyrazolecarboxamide substitué. |
| FR2789079B3 (fr) * | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
-
2000
- 2000-05-12 FR FR0006178A patent/FR2809621B1/fr not_active Expired - Fee Related
-
2001
- 2001-05-11 AU AU2001260406A patent/AU2001260406A1/en not_active Abandoned
- 2001-05-11 WO PCT/FR2001/001432 patent/WO2001085092A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| FR2809621A1 (fr) | 2001-12-07 |
| WO2001085092A3 (fr) | 2002-08-29 |
| FR2809621B1 (fr) | 2002-09-06 |
| WO2001085092A2 (fr) | 2001-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AUPR833401A0 (en) | G protein-coupled receptor antagonists | |
| AU2001250205A1 (en) | Prostaglandin d2 receptor antagonists | |
| AU2001264657A1 (en) | Crf receptor antagonists | |
| AU2001260406A1 (en) | Antidiarrheal cannabinoid cb-1 receptor antagonist | |
| AU2002365655A1 (en) | 5-ht7 receptor antagonists | |
| AU2001286409A1 (en) | N-methyl-d-aspartate receptor antagonists | |
| AU2001240021A1 (en) | Diazafluorenone il-8 receptor antagonists | |
| AU2001245724A1 (en) | Il-8 receptor antagonists | |
| AU2002216079A1 (en) | Bombesin receptor antagonists | |
| AU2001243351A1 (en) | Il-8 receptor antagonists | |
| AU2001240097A1 (en) | G protein-coupled receptors | |
| AU2002226048A1 (en) | Urotensin-ii receptor antagonists | |
| AU2002239506A1 (en) | Urotensin-ii receptor antagonists | |
| AU2001263288A1 (en) | Crf receptor antagonists | |
| AU2001241896A1 (en) | Il-8 receptor antagonists | |
| AU2002359524A1 (en) | P2x7 receptor antagonists | |
| AU2002217095A1 (en) | Bombesin receptor antagonists | |
| AU2001253172A1 (en) | Il-8 receptor antagonists | |
| AU2001223882A1 (en) | Receptor | |
| AU2001249922A1 (en) | G protein-coupled receptors | |
| AUPQ563400A0 (en) | Novel receptor | |
| AU2001245605A1 (en) | Il-8 receptor antagonists | |
| AU2001259322A1 (en) | G protein-coupled receptors | |
| AU2001257231A1 (en) | Novel g protein-coupled receptors | |
| AU2001255472A1 (en) | Novel g protein-coupled receptor con-218 |